10.18.21 -- Achieving Manufacturing Compliance, Process Improvement, And Cost Containment

To ensure that a commercial biomanufacturing process is in a state of control, life sciences companies must create and successfully execute initiatives to meet continued process verification (CPV) and other monitoring guidelines. In this white paper, learn how to navigate the major steps of implementing a global monitoring plan for continued process verification.

Without software applications, life sciences organizations have limited visibility into their quality or process data. With continued process verification (CPV), you can meet your monitoring needs and improve collaboration with your contract manufacturers.

Speeding innovative and successful new drugs to patients will require the end-to-end, digital transformation of CMC processes. This webcast explores how “always-on” digital lab informatics services can improve collaborative innovation and productivity across your global CMC organization.

A biopharmaceutical manufacturer was facing a challenge in ensuring consistent continued process verification (CPV) initiatives across their different manufacturing sites. A software solution that was purpose-built for biopharmaceutical manufacturing provided a strong foundation to streamline the validation of manufacturing analytics for CPV and reporting.

Data gathering was difficult for an emerging specialty pharmaceutical company, as data resided in paper-based documents, spreadsheets, and complex equipment systems. The inability to garner insights from the data for impactful decisions drove them to seek a solution that could accelerate data aggregation, modeling and prediction.

Following several mergers and acquisitions, a biopharmaceutical company had to manage an increasing amount of data from disparate online and offline sources. A solution allowed them to access data from various sources and to feed other systems with data quickly to support the company’s digital science and manufacturing informatics strategies.